Broadwood pledges cooperation with STAAR Surgical after Alcon deal vote
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
December 17, 2025 1:17 PM ESTExpresses Confidence in STAARs Future and the Opportunity for Significant Value Creation
Believes STAAR is Worth at Least $50 Per Share If the Company Is Run in Best Interest of Shareholders
NEW YORK--(BUSINESS WIRE)-- Broadwood Partners, L.P. and its affiliates (collectively, Broadwood) today issued the following letter to the Board of Directors (the Board) of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA). Broadwood, which owns 30.2% of STAARs outstanding common stock, continues to urge its fellow shareholders to vote... More
